Author

Miguel Foronda

Primary ORCID profile (0000-0001-9590-9281 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Miguel ForondaiD2 papers · Weill Cornell Medicine

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:drug response / drug discovery· 1 Research Focus:gene regulatory network inference· 1 Organism:human· 1 Approach:machine learning (classical)· 1

Frequent Co-Authors

Alexendar Perez· 1 shared Christina S. Leslie· 1 shared Coryandar GilvaryiD· 1 shared Gaurav Pandey· 1 shared Kaitlyn Gayvert· 1 shared Lukas Dow· 1 shared Neel S. MadhukariD· 1 shared Olivier ElementoiD· 1 shared

Activity by Year

2019-2019 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alexendar Perez

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Cancer BiologybioRxivPreprintJul 4, 2019

A machine learning approach predicts essential genes and pharmacological targets in cancer

Coryandar Gilvary, Neel S. Madhukar, Kaitlyn Gayvert…·Olivier Elemento

This paper introduces ECLIPSE, a machine learning model that predicts essential genes and pharmacological targets in cancer by integrating genomic, cell line, and experimental features, showing better differentiation of approved cancer drugs from non-approved ones.

DOI 10.1101/692277

humanbulk RNA-seq

𝕏 PostBluesky